GlaxoSmithKline PLC

LON100:GSK, Dec 18, 08:40 UTC FTSE 100 real-time data - Disclaimer Currency in GBP

Latest LON100:GSK News

Filter your feed

Apply Filter

Yesterday


News

Community Financial Services Group Boosted Glaxosmithkline Plc (GSK) Stake; 21 Analysts Bullish Biogen Inc. (BIIB) - The San Times

GSK GSK

The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Friday, July 14 by Nomura. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Hold” rating by RBC Capital Markets on Wednesday, October 25. As per Monday, November 7, the company rating was upgraded by Piper Jaffray. Comerica Bank has 0.13% invested in Biogen Inc. (NASDAQ:BIIB) for 59,274 shares. Artemis Investment Mgmt Ltd Liability Partnership owns 0.09% invested in Biogen Inc. (NASDAQ:BIIB) for 14,339 shares.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Phoenix Investment Adviser Has Boosted Kindred Healthcare (KND) Holding By $341,000; Bank Of Hawaii Cut Glaxosmithkline Plc (GSK) Stake - The San Times

GSK GSK

Wetherby Asset holds 0.63% of its portfolio in AT&T Inc. (NYSE:T) for 97,364 shares. Moreover, Sonata Capital Grp has 0.46% invested in AT&T Inc. (NYSE:T) for 16,343 shares. Among 10 analysts covering Kindred Healthcare Inc. (NYSE:KND), 2 have Buy rating, 1 Sell and 7 Hold. Among 29 analysts covering AT&T Inc. (NYSE:T), 10 have Buy rating, 1 Sell and 18 Hold.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, December 16


News

As Glaxosmithkline Plc (GSK) Share Value Rose, Holder Rfg Advisory Group Decreased Stake; Martin Marietta Matls (MLM) Stock Value Rose While Alkeon Capital Management Lifted Stake - Flint Daily

GSK GSK

Rfg Advisory Group Llc sold 8,410 shares as the company’s stock rose 5.47% with the market. Alkeon Capital Management Llc bought 207,918 shares as the company’s stock rose 4.98% with the market. SunTrust maintained Martin Marietta Materials, Inc. (NYSE:MLM) on Thursday, October 26 with “Buy” rating. Among 13 analysts covering Martin Marietta (NYSE:MLM), 8 have Buy rating, 0 Sell and 5 Hold.

Read Full Details

Topics:
  • Business
  • Financial
News

Cormorant Asset Management Has Lifted Portola Pharmaceuticals (PTLA) Position By $16.80 Million; Last Week GlaxoSmithKline plc (LON:GSK) Coverage - Key Gazette

GSK GSK

Deutsche Bank maintained GlaxoSmithKline plc (LON:GSK) on Thursday, October 27 with “Hold” rating. The stock of GlaxoSmithKline plc (LON:GSK) has “Neutral” rating given on Thursday, July 13 by JP Morgan. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) earned “Outperform” rating by Credit Suisse on Monday, March 28. The rating was maintained by Citigroup on Monday, June 26 with “Buy”. Martingale Asset Management Lp reported 0.01% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA).

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

GlaxoSmithKline (GSK) Earns “Neutral” Rating from Citigroup – Week Herald

GSK GSK +1 more GSK GSK C

Morgan Stanley set a GBX 1,450 ($19.52) target price on GlaxoSmithKline and gave the company a sell rating in a research report on Monday, November 6th. Deutsche Bank set a GBX 1,610 ($21.67) target price on GlaxoSmithKline and gave the company a neutral rating in a research report on Friday, October 27th. Stockholders of record on Thursday, November 9th will be given a dividend of GBX 19 ($0.26) per share. Also, insider Simon Dingemans purchased 1,076 shares of the stock in a transaction dated Thursday, October 12th.

Read Full Details

Topics:
  • Business
  • Financial
News

Investment Centers Of America Lowered By $429,156 Its Glaxosmithkline Plc (GSK) Position; 3 Analysts Are Bullish ALLIED PROPERTIES REAL ESTATE I (TSE:AP_U) Last Week - Utah Herald

GSK GSK

Among 5 analysts covering Allied Properties REIT (TSE:AP_U), 3 have Buy rating, 0 Sell and 2 Hold. 3 Analysts Are Bullish ALLIED PROPERTIES REAL ESTATE I (TSE:AP_U) Last Week. Investment Centers Of America Inc sold 10,218 shares as Glaxosmithkline Plc (GSK)’s stock rose 5.47%. Investment Centers Of America Inc decreased Glaxosmithkline Plc (GSK) stake by 29.05% reported in 2017Q2 SEC filing.

Read Full Details

Topics:
  • Business
  • Financial
News

Sterneck Capital Management LLC Decreased Glaxosmithkline Plc (GSK) Holding by $3.24 Million;

GSK GSK

Sterneck Capital Management Llc decreased its stake in Glaxosmithkline Plc (GSK) by 77.37% based on its latest 2017Q2 regulatory filing with the SEC. Sterneck Capital Management Llc who had been investing in Glaxosmithkline Plc for a number of months, seems to be less bullish one the $81.00B market cap company. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Buy” rating given on Wednesday, December 9 by Bank of America. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Underperform” rating by BNP Paribas on Wednesday, September 14. The firm earned “Neutral” rating on Tuesday, October 20 by Credit Suisse.

Read Full Details

Topics:
  • Business
  • Financial
  • Entertainment

Friday, December 15


News

Sales Growth Analysis: GlaxoSmithKline plc (GSK), Caterpillar Inc. (CAT)

GSK GSK +1 more GSK GSK CAT

Increasing profits are the best indication that a company can pay dividends and that the share price will trend upward. It tells an investor how quickly a company is increasing its revenues. The bad news is analysts don’t believe there’s a room for Caterpillar Inc. (CAT) to move in the upward direction. Caterpillar Inc. (NYSE:CAT) is another stock that is grabbing investors attention these days.

Read Full Details

Topics:
  • Business
  • Financial
News

Stocks for Your Case: FS Investment Corporation (FSIC), GlaxoSmithKline plc (GSK)

GSK GSK

FS Investment Corporation (FSIC) analysts on average have given a price target of $9.3 on FSIC stock. FS Investment Corporation (FSIC) ended its previous trading session at $7.8 with the Loss of 0%. The low EPS estimate is $0.62, while the high EPS estimate is $0.68. Average Revenue Estimate of the company for the current Fiscal Quarter is $10.04 Billion, according to consensus of 4 analysts. GlaxoSmithKline plc (GSK) analysts on average have given a price target of $9.3 on GSK stock.

Read Full Details

Topics:
  • Business
  • Financial
News

GlaxoSmithKline PLC (GS7A.DE): Piotroski F Score Reading Above Five on These Shares

GSK GSK

The Average Directional Index or ADX is a technical analysis indicator used to describe if a market is trending or not trending. Moving averages have the ability to be used as a powerful indicator for technical stock analysis. As a momentum indicator, the Williams R% may be used with other technicals to help define a specific trend. The 14-day RSI is presently standing at 43.28, the 7-day is 47.53, and the 3-day is resting at 40.88. Investors may use multiple technical indicators to help spot trends and buy/sell signals.

Read Full Details

Topics:
  • Business
  • Financial